Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Avalon GloboCare (ALBT) EBITDA (2016 - 2025)

Historic EBITDA for Avalon GloboCare (ALBT) over the last 10 years, with Q3 2025 value amounting to -$253997.0.

  • Avalon GloboCare's EBITDA rose 8484.65% to -$253997.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$18.9 million, marking a year-over-year decrease of 2842.8%. This contributed to the annual value of -$7.9 million for FY2024, which is 5274.51% up from last year.
  • As of Q3 2025, Avalon GloboCare's EBITDA stood at -$253997.0, which was up 8484.65% from -$13.5 million recorded in Q2 2025.
  • Avalon GloboCare's 5-year EBITDA high stood at -$253997.0 for Q3 2025, and its period low was -$13.5 million during Q2 2025.
  • Its 5-year average for EBITDA is -$3.3 million, with a median of -$2.4 million in 2021.
  • Within the past 5 years, the most significant YoY rise in Avalon GloboCare's EBITDA was 8484.65% (2025), while the steepest drop was 53205.6% (2025).
  • Avalon GloboCare's EBITDA (Quarter) stood at -$2.3 million in 2021, then decreased by 2.79% to -$2.4 million in 2022, then plummeted by 300.4% to -$9.6 million in 2023, then skyrocketed by 71.46% to -$2.7 million in 2024, then soared by 90.69% to -$253997.0 in 2025.
  • Its EBITDA was -$253997.0 in Q3 2025, compared to -$13.5 million in Q2 2025 and -$2.5 million in Q1 2025.